Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review. (13th June 2020)

• Record Type: Journal Article
• Authors: Sakai, Tomohisa; Hamada, Shunsuke; Koike, Hiroshi; Shimizu, Koki; Yoshida, Masahiro; Nishida, Yoshihiro
• Is Part Of: Japanese journal of clinical oncology. Volume 50:Number 9(2020)
• Page Start: 1037
• Page End: 1042
• Publication Date: 2020-06-13
• Subjects: desmoid-type fibromatosis -- beta-catenin -- CTNNB1 -- mutation analysis -- systematic review; Oncology -- Periodicals; Cancer -- Periodicals; 616.994005
• DOI: 10.1093/jjco/hyaa080
• Languages: English
• ISSNs: 0368-2811

Abstract

Abstract: Background: An accurate diagnosis is crucial to determine the treatment modality for desmoid-type fibromatosis, although the histopathological diagnosis is occasionally difficult to make. Many desmoid-type fibromatosis have been reported to have hotspot mutation of β-catenin gene ( CTNNB1 ). In the present study, we performed a systematic review to verify the usefulness of CTNNB1 mutation analysis in the diagnosis of desmoid-type fibromatosis. Methods: A literature search from January 1990 to August 2017 was conducted. Three reviewers independently assessed and screened the literature for eligibility and determined the final articles to be evaluated. Data regarding the sensitivity, specificity, accuracy and usefulness of CTNNB1 mutation analysis in the diagnosis of desmoid-type fibromatosis were recorded. We rated each report according to the Grading of Recommendations Development and Evaluation approach. Results: The search yielded 90 studies, seven of which were included after the first and second screenings. The positive rate of CTNNB1 mutation in desmoid-type fibromatosis was 86.8%, but the cohort of six of the seven reports was already diagnosed histopathologically as desmoid-type fibromatosis. Therefore, the usefulness of CTNNB1 mutation analysis in a cohort that is difficult to diagnose histopathologically is not clear in this review. Nevertheless, CTNNB1 mutation showed very high specificity in desmoid-type fibromatosis, indicating the usefulness of CTNNB1 mutation analysis in its diagnosis in combination with histological examination. Conclusion: Because the lack of data precludes any useful comparison with histological diagnosis, the evidence level is low. However, considering its specificity, CTNNB1 mutation analysis may be useful in cases in which the histopathological diagnosis is difficult. Abstract : We performed a systematic review to verify the usefulness of CTNNB1 mutation analysis in the diagnosis of DF. It may be useful for the cases that have difficulty in histopathological diagnosis.